Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D9FW
|
||||
| Former ID |
DIB000208
|
||||
| Drug Name |
DP-VPA
|
||||
| Synonyms |
TVA; Valproic acid; RAP-valproate; SPD-421; Valproic acid prodrug, Shire; RAP-valproate, D-Pharm
|
||||
| Indication | Bipolar disorder [ICD9: 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300; ICD10:F31, F40-F42] | Approved | [1] | ||
| Company |
D-Pharm Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
P(=O)(OCC(OC(=O)C(CCC)CCC)CO*)(OCC[N+](C)(C)C)[O-]
|
||||
| Target and Pathway | |||||
| Target(s) | Gamma-aminobutyric acid receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008928) | ||||
| REF 2 | DP-VPA D-Pharm. Curr Opin Investig Drugs. 2002 Jun;3(6):921-3. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.